Skip to contentBASKETT FOREST — DATATRAK INTERNATIONAL INC insider: 1,000 transactions · InsiderLensBASKETT FOREST
- 10% owner at Sagimet Biosciences Inc. · on record since Jul 20, 2023
- Director at ATHEROS COMMUNICATIONS INC · on record since Feb 9, 2006
- 10% owner at AMICUS THERAPEUTICS INC · on record since May 31, 2007
- 10% owner at Korro Bio, Inc. · on record since Nov 7, 2023
- 10% owner at INNERWORKINGS INC · on record since Aug 15, 2006
- 10% owner at HEMOSENSE INC · on record since Dec 21, 2006
- 10% owner at MBX Biosciences, Inc. · on record since Sep 17, 2024
- 10% owner at PEPLIN INC · on record since Oct 30, 2008
- Director at Bright Health Group Inc. · on record since Oct 6, 2025
- 10% owner at ARYx Therapeutics, Inc. · on record since Nov 14, 2008
- 10% owner at Clovis Oncology, Inc. · on record since Nov 22, 2011
- 10% owner at SCHERING PLOUGH CORP · on record since Feb 11, 2026
- 10% owner at SUNESIS PHARMACEUTICALS INC · on record since Apr 6, 2009
- 10% owner at ELECTRONIC CLEARING HOUSE INC · on record since Oct 1, 2009
- Director at FUSION-IO, INC. · on record since Jun 16, 2011
- 10% owner at FUSION-IO, INC. · on record since Jun 16, 2011
- 10% owner at Ra Pharmaceuticals, Inc. · on record since Oct 31, 2016
- 10% owner at Groupon, Inc. · on record since Nov 3, 2011
- 10% owner at METAL MANAGEMENT INC · on record since Mar 28, 2012
- 10% owner at SUPERNUS PHARMACEUTICALS INC · on record since Apr 30, 2012
- 10% owner at TESARO, Inc. · on record since Jun 27, 2012
- Director at AUDIENCE INC · on record since May 16, 2012
- 10% owner at AUDIENCE INC · on record since May 16, 2012
- 10% owner at HYPERION THERAPEUTICS INC · on record since Jul 25, 2012
- 10% owner at Workday, Inc. · on record since Oct 18, 2012
- 10% owner at XOOM Corp · on record since Feb 25, 2013
- 10% owner at Epizyme, Inc. · on record since May 30, 2013
- 10% owner at CHANNELADVISOR CORP · on record since May 29, 2013
- Director at DATATRAK INTERNATIONAL INC · on record since May 23, 2013
- 10% owner at DATATRAK INTERNATIONAL INC · on record since May 23, 2013
- 10% owner at INTERLEUKIN GENETICS INC · on record since May 23, 2013
- 10% owner at Omthera Pharmaceuticals, Inc. · on record since Apr 17, 2013
- Director at Omthera Pharmaceuticals, Inc. · on record since Jul 18, 2013
- 10% owner at TCW CONVERTIBLE SECURITIES FUND INC · on record since Aug 14, 2013
- 10% owner at TREVENA INC · on record since Jan 30, 2014
- 10% owner at Care.com Inc · on record since Jan 29, 2014
- 10% owner at HIVE Digital Technologies Ltd. · on record since Mar 27, 2014
- 10% owner at GLYCOMIMETICS INC · on record since Jan 15, 2014
- 10% owner at ARDELYX, INC. · on record since Jun 26, 2014
- 10% owner at TriVascular Technologies, Inc. · on record since Apr 24, 2014
- 10% owner at OPOWER, INC. · on record since Apr 9, 2014
- 10% owner at OnKure Therapeutics, Inc. · on record since Apr 15, 2021
- 10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
- 10% owner at Roka BioScience, Inc. · on record since Jul 22, 2014
- 10% owner at Journey Medical Corp · on record since Oct 8, 2014
- 10% owner at Tracon Pharmaceuticals, Inc. · on record since Jan 29, 2015
- 10% owner at SeaCube Container Leasing Ltd. · on record since Jan 29, 2015
- 10% owner at Zosano Pharma Corp · on record since Jan 26, 2015
- 10% owner at CHAMPIONS SPORTS INC · on record since Mar 24, 2015
- 10% owner at NUVELO INC · on record since Jun 17, 2015
- 10% owner at Mirna Therapeutics, Inc. · on record since Sep 30, 2015
- 10% owner at ADVANCE TECHNOLOGIES INC · on record since Oct 20, 2015
- 10% owner at PERFORMANCE TECHNOLOGIES INC \DE\ · on record since Feb 17, 2016
- 10% owner at Adaptimmune Therapeutics PLC · on record since Jan 4, 2016
- 10% owner at AVEO PHARMACEUTICALS INC · on record since May 17, 2016
- 10% owner at Achaogen Inc · on record since Jun 7, 2016
- 10% owner at MULESOFT, INC · on record since Mar 22, 2017
- 10% owner at CASCADE CORP · on record since Feb 1, 2017
- 10% owner at APPIAN CORP · on record since May 31, 2017
- 10% owner at Tintri, Inc. · on record since Jun 29, 2017
- 10% owner at Mersana Therapeutics, Inc. · on record since Jun 27, 2017
- 10% owner at Regulus Therapeutics Inc. · on record since Jul 31, 2017
- 10% owner at ACTELIS NETWORKS INC · on record since Nov 20, 2017
- 10% owner at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 10, 2017
- 10% owner at GENOCEA BIOSCIENCES, INC. · on record since Jan 23, 2018
- 10% owner at Strongbridge Biopharma plc · on record since Jan 9, 2018
- 10% owner at Surface Oncology, Inc. · on record since Apr 23, 2018
- 10% owner at Liquidia Corp · on record since Jul 25, 2018
- 10% owner at PhaseBio Pharmaceuticals Inc · on record since Oct 24, 2018
- 10% owner at TAPIMMUNE INC · on record since Oct 18, 2018
- 10% owner at Tempest Therapeutics, Inc. · on record since Dec 11, 2018
- 10% owner at Elastic N.V. · on record since Oct 10, 2018
- 10% owner at KNIGHT CAPITAL GROUP, INC. · on record since Jan 2, 2019
- 10% owner at Trevi Therapeutics, Inc. · on record since May 13, 2019
- 10% owner at Mirum Pharmaceuticals, Inc. · on record since Jul 24, 2019
- 10% owner at Cloudflare, Inc. · on record since Sep 18, 2019
- 10% owner at Oyster Point Pharma, Inc. · on record since Oct 30, 2019
- 10% owner at ST PAUL TRAVELERS COMPANIES INC · on record since Dec 18, 2019
- 10% owner at Galera Therapeutics, Inc. · on record since Nov 12, 2019
- 10% owner at Revolution Acceleration Acquisition Corp · on record since Jul 30, 2021
- 10% owner at Black Diamond Therapeutics, Inc. · on record since Jan 29, 2020
- 10% owner at 11 GOOD ENERGY INC · on record since Mar 16, 2020
- 10% owner at Casper Sleep Inc. · on record since Feb 12, 2020
- 10% owner at Akouos, Inc. · on record since Jun 25, 2020
- 10% owner at Inozyme Pharma, Inc. · on record since Jul 28, 2020
- 10% owner at Annexon, Inc. · on record since Jul 23, 2020
- 10% owner at Metacrine, Inc. · on record since Sep 22, 2020
- 10% owner at Nkarta, Inc. · on record since Jul 16, 2020
- 10% owner at HEARUSA INC · on record since Oct 22, 2020
- 10% owner at Dolan Media CO · on record since Dec 11, 2020
- 10% owner at Coursera, Inc. · on record since Mar 30, 2021
- Director at Robinhood Markets, Inc. · on record since Jul 29, 2021
- 10% owner at Robinhood Markets, Inc. · on record since Jul 29, 2021
- 10% owner at ADVENTRX PHARMACEUTICALS INC · on record since Mar 16, 2021
- Former 10% Owner at Regulus Therapeutics Inc. · on record since Mar 16, 2021
- 10% owner at Verona Pharma plc · on record since Jan 4, 2021
- 10% owner at Bright Health Group Inc. · on record since Jun 30, 2021
- 10% owner at Monte Rosa Therapeutics, Inc. · on record since Jun 30, 2021
- 10% owner at MINERVA SURGICAL INC · on record since Oct 28, 2021
- 10% owner at BuzzFeed, Inc. · on record since Dec 7, 2021
- 10% owner at IonQ, Inc. · on record since Oct 4, 2021
- 10% owner at Arcellx, Inc. · on record since Feb 9, 2022
- 10% owner at SENESCO TECHNOLOGIES INC · on record since Jun 15, 2022
- 10% owner at L&F Acquisition Corp. · on record since Aug 5, 2022
Insider trading activity of BASKETT FOREST
- Transactions on record
- 1,000
- since Feb 20, 2004
- Open-market buys
- 118
- $580.3M
- Open-market sells
- 164
- $894.5M
- Companies traded
- 73
- last filing Mar 12, 2026
Figures computed from official regulatory filings — methodology.
Companies where BASKETT FOREST has traded
- Korro Bio, Inc.3 tx · $6M · Mar 12, 2026
- Trevi Therapeutics, Inc.13 tx · $32.5M · Feb 13, 2026
- SCHERING PLOUGH CORP13 tx · $15M · Feb 11, 2026
- Bright Health Group Inc.58 tx · $147.7M · Oct 6, 2025
- BuzzFeed, Inc.3 tx · $44.6K · Mar 6, 2025
- MBX Biosciences, Inc.5 tx · $8M · Sep 17, 2024
- Sagimet Biosciences Inc.4 tx · Jan 31, 2024
- ADVENTRX PHARMACEUTICALS INC1 tx · $1M · Jul 19, 2023
- Mirum Pharmaceuticals, Inc.7 tx · $6.8M · Jun 15, 2023
Track record of BASKETT FOREST
Statistical track record
Free- Open-market buys
- 150
- Last buy
- Mar 10, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of BASKETT FOREST
Co-insiders of BASKETT FOREST
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
20 tx · Feb 17, 2023
New Enterprise Associates 15, L.P.Annexon, Inc. +11
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Mar 12, 2026 | BuyD | 242,945 | 11.11 USD | $2.7M | SEC |
| Mar 12, 2026 | Buy | 207,100 | 11.11 USD | $2.3M | SEC |
| Feb 13, 2026 | OtherD | -1,851,852 | 0.00 USD | $0 | SEC |
| Feb 13, 2026 | Other | 1,851,852 | 1.37 USD | $2.5M | SEC |
| Feb 11, 2026 | Other | 1,370,168 | — | — | SEC |
| Feb 11, 2026 | OtherD | -954,990 | — | — | SEC |
| Feb 11, 2026 | Other | 737,962 | — | — | SEC |
| Feb 11, 2026 | Buy | 937,500 | 16.00 USD | $15M | SEC |
| Feb 11, 2026 | Other | 1,370,168 | — | — | SEC |
| Feb 11, 2026 | Other | 402,273 | — | — | SEC |
| Feb 11, 2026 | OtherD | -402,273 | — | — | SEC |
| Feb 11, 2026 | OtherD | -1,619,240 | — | — | SEC |
| Feb 11, 2026 | OtherD | -1,370,168 | — | — | SEC |
| Feb 11, 2026 | OtherD | -1,370,168 | — | — | SEC |
| Feb 11, 2026 | OtherD | -737,962 | — | — | SEC |
| Feb 11, 2026 | Other | 954,990 | — | — | SEC |
| Feb 11, 2026 | Other | 1,619,240 | — | — | SEC |
| Oct 6, 2025 | Other | -1,960,591 | — | — | SEC |
| Oct 6, 2025 | OtherD | -37,700 | — | — | SEC |
| Oct 6, 2025 | Other | 189,195 | 0.01 USD | $1.9K | SEC |
| Oct 6, 2025 | Other | 189,195 | 0.01 USD | $1.9K | SEC |
| Oct 6, 2025 | Sell | -280 | 6.75 USD | $1.9K | SEC |
| Oct 6, 2025 | Other | -643 | 6.75 USD | $4.3K | SEC |
| Oct 6, 2025 | ExerciseD | -186,128 | 0.00 USD | $0 | SEC |
| Oct 6, 2025 | Other | -674,554 | — | — | SEC |